| Characteristics | Total | Group I ( | Group II () | Group III () | value |
| Number | 891 | 325 | 397 | 169 | | Demographics | | | | | | Age, years | 71.8 (61.6-80.8) | 68.2 (58.9-80.2) | 73.0 (62.9-81.2) | 74.1 (65.1-80.6) | 0.004 | Sex, male | 532 (59.7%) | 182 (56.0%) | 250 (63.0%) | 100 (59.2%) | 0.162 | Smoking | 463 (52.0%) | 165 (50.8%) | 218 (54.9%) | 80 (47.3%) | 0.221 | BMI, kg/m2 | 27.6 (23.8-31.6) | 27.7 (23.8-31.8) | 27.7 (23.6-31.8) | 27.5 (23.9-30.2) | 0.618 | Etiology | | | | | <0.001 | AMI | 671 (75.4%) | 215 (66.2%) | 312 (78.6%) | 144 (85.2%) | | AHF | 179 (20.1%) | 89 (27.4%) | 73 (18.4%) | 17 (10.1%) | | Others/unknown | 41 (4.5%) | 21 (6.5%) | 12 (3.0%) | 8 (4.7%) | | History of disease | | | | | | CHF | 190 (21.3%) | 92 (28.3%) | 79 (19.9%) | 19 (11.2%) | 0.002 | AF | 431 (48.4%) | 140 (43.1%) | 198 (49.9%) | 93 (55.0%) | 0.030 | CAD | 472 (53.0%) | 184 (56.6%) | 206 (51.9%) | 82 (48.5%) | 0.196 | Hypertension | 177 (19.9%) | 64 (19.7%) | 88 (22.2%) | 25 (14.8%) | 0.131 | Stroke | 26 (2.9%) | 14 (4.3%) | 11 (2.8%) | 1 (0.6%) | 0.057 | COPD | 23 (2.6%) | 4 (1.23%) | 10 (2.5%) | 9 (5.3%) | 0.031 | DM | 332 (37.3%) | 126 (38.8%) | 148 (37.3%) | 58 (34.3%) | 0.624 | CKD | 240 (26.9%) | 81 (24.9%) | 121 (30.5%) | 38 (22.5%) | 0.086 | Vital signs at presentation | | | | | | SBP, mmHg | 77.0 (67.0-86.0) | 77.0 (67.0-87.0) | 77.0 (68.0-86.0) | 77.0 (65.0-85.0) | 0.236 | DBP, mmHg | 46.0 (38.3-52.0) | 46.0 (38.0-52.0) | 46.0 (37.0-52.0) | 44.0 (36.0-51.0) | 0.704 | HR, beats/min | 99.0 (84.0-116.0) | 97.0 (82.0-113.0) | 101.0 (85.0-115.0) | 101.0 (84.0-118.0) | 0.194 | SpO2, % | 92.0 (88.0-95.0) | 93.0 (88.0-95.0) | 92.0 (87.0-95.0) | 92.0 (88.0-95.0) | 0.148 | Laboratory findings and blood gas analysis | | | | | | Neutrophil percentage, % | 82.8 (75.0-88.0) | 75.8 (68.0-84.2) | 84.0 (78.6-88.4) | 87.8 (82.5-91.2) | <0.001 | Albumin, mg/dL | 3.0 (2.6-3.4) | 3.5 (3.1-3.7) | 2.900 (2.6-3.1) | 2.4 (2.2-2.6) | <0.001 | Creatinine, μmol/L | 1.3 (0.9-2.2) | 1.2 (0.9-2.0) | 1.4 (1.0-2.3) | 1.40 (1.0-2.2) | 0.043 | Glucose, mg/dL | 113.0 (92.0-139.5) | 110.0 (91.0-135.0) | 112.0 (93.0-140.0) | 119.0 (92.0-143.0) | 0.327 | BUN, mg/dL | 29.0 (19.0-47.0) | 25.0 (18.0-45.0) | 29.0 (20.0-50.0) | 32.0 (20.0-45.0) | 0.024 | Hemoglobin, g/dL | 9.80 (8.40-11.30) | 10.300 (8.6-11.8) | 9.600 (8.4-11.0) | 9.5 (8.2-10.7) | 0.002 | Platelet, 109/L | 187.00 (132.0-253.0) | 182.0 (136.0-243.0) | 192.0 (135.0-264.0) | 181.0 (126.0-242.0) | 0.249 | WBC, 109/L | 14.90 (11.10-19.50) | 13.7 (10.2-18.2) | 15.9 (11.9-20.2) | 15.4 (12.0-19.8) | <0.001 | cTnT, ng/mL | 1.04 (0.12-4.67) | 0.8 (0.1-3.8) | 1.2 (0.2-5.0) | 1.0 (0.1-5.7) | 0.052 | Bicarbonate, mmol/L | 20.0 (17.0-23.0) | 21.0 (18.0-24.0) | 20.0 (17.0-23.0) | 18.0 (15.0-22.0) | <0.001 | Potassium, mmol/L | 3.70 (3.40-4.20) | 3.7 (3.4-4.1) | 3.8 (3.4-4.2) | 3.7 (3.3-4.3) | 0.374 | Sodium, mmol/L | 135.00 (132.00-138.00) | 135.0 (133.0-138.0) | 135.0 (132.0-138.0) | 135.0 (132.0-138.0) | 0.635 | Chloride, mmol/L | 101.00 (97.00-105.00) | 101.0 (98.0-105.0) | 101.0 (97.0-105.0) | 102.0 (98.0-106.0) | 0.121 | Lactate, mmol/L | 3.30 (1.90-6.10) | 3.0 (1.6-5.6) | 3.3 (1.9-6.1) | 3.8 (2.2-6.3) | 0.010 | Anion gap, mmol/L | 14.0 (12.0-17.0) | 14.0 (12.0-16.0) | 14.0 (12.0-17.0) | 15.0 (12.0-17.0) | 0.027 | APTT, second | 32.7 (27.9-41.2) | 31.9 (26.9-38.6) | 33.2 (28.0-43.0) | 34.7 (29.5-43.3) | 0.002 | PT, second | 14.5 (13.2-17.5) | 14.2 (13.0-15.9) | 14.6 (13.3-17.6) | 15.4 (13.5-18.9) | <0.001 | INR | 1.3 (1.2-1.7) | 1.3 (1.1-1.5) | 1.3 (1.2-1.7) | 1.4 (1.2-1.8) | <0.001 | Scoring system | | | | | | OASIS | 37.0 (31.0-43.0) | 34.0 (27.0-40.0) | 38.0 (32.0-43.0) | 41.0 (36.0-47.0) | <0.001 | SOFA | 7.0 (4.0-9.0) | 6.0 (4.0-9.0) | 7.0 (5.0-10.0) | 8.0 (6.0-10.0) | <0.001 | SAPS II | 47.0 (37.0-56.0) | 42.0 (32.0-52.0) | 48.0 (39.0-58.0) | 51.0 (44.0-59.0) | <0.001 | In-hospital management | | | | | | Oxygen therapy | 670 (75.2%) | 217 (66.8%) | 307 (77.3%) | 146 (86.4%) | <0.001 | PCI | 502 (56.3%) | 179 (55.1%) | 228 (57.4%) | 95 (56.2%) | 0.594 | CABG | 119 (13.4%) | 64 (19.7%) | 44 (11.1%) | 11 (6.5%) | <0.001 | IABP | 9 (1.0%) | 1 (0.3%) | 5 (1.3%) | 3 (1.8%) | 0.196 | RRT | 175 (19.6%) | 53 (16.3%) | 83 (20.9%) | 39 (23.1%) | 0.138 | In-hospital medication | | | | | | Inotrope | 352 (39.5%) | 121 (37.2%) | 151 (38.0%) | 80 (47.3%) | 0.067 | Vasoconstrictor | 651 (73.1%) | 218 (67.1%) | 296 (74.6%) | 137 (81.1%) | 0.003 |
|
|